• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Publication

Article

November 15, 2018

Specialty Pharmacy Times

November/December
Volume9
Issue 7

The Era of Specialty: An Update on Current Industry Trends

Author(s):

Jennifer Barrett, Associate Editor

In a presentation held at the 2018 National Association of Specialty Pharmacy Annual Meeting and Educational Conference, Doug Long, MBA, provided insight into the growth of specialty, citing several areas to watch over the next few years.

As specialty drug development and costs continue to dominate the market, several ongoing and emerging trends in the industry will likely have a significant impact. In a presentation held at the 2018 National Association of Specialty Pharmacy Annual Meeting and Educational Conference, Doug Long, MBA, provided insight into the growth of specialty, citing several areas to watch over the next few years.

INDUSTRY GROWTH

Specialty medicines continue to drive all spending growth in developed markets, as branded medicine spending falls. In 2017, specialty drugs accounted for one-third of the pharmacy industry’s total prescription dispensing revenues, according to the presentation. Currently, oncology, autoimmune, and HIV therapeutics lead absolute value growth among the top specialty therapy areas.

“We are truly in the era of specialty,” Long told the audience, noting that most drug launches have shifted to specialty. Of the 42 medicines approved last year, 21 had orphan designations, 19 were breakthrough therapies, and 2 were gene therapies. Looking ahead, Long noted that the late-stage pipeline remains robust with a focus on cancer and nervous system disorders, indicating that specialty drug growth will continue to trend upward.

MARKET ACCESS

Payer grip continues to tighten, as management across brands increases, according to the presentation. Managed care organizations and pharmacy benefit managers (PBMs) are increasingly using strict approaches to manage drugs, including the use of formulary exclusions, which continue to grow. Long also noted that access is now discussed in terms of “winning and losing” based on negotiations with major PBMs and payers.

Additionally, patients are facing increasing financial pressure, as payers are transferring higher percentages of costs to patients. According to Long, the average commercial co-pay increase from 2016 to 2017 was 14% and out-of-pocket health spending is projected to increase. Moving forward, addressing issues such as price transparency and value-based contracting will be key in improving access challenges.

INNOVATION

As digital health becomes more integrated with specialty pharmacy, the use of real-world data and evidence in clinical practice guided by the FDA will play a significant role, Long said. Additionally, telehealth and health app use is trending up; both can potentially address challenges, such as adherence, which affect patient care.

“If there is a shortage of doctors, telehealth is going to play a bigger role in the future,” Long said. According to Long, US telehealth visits are expected to grow between 4.2% and 7.5% from 2017 to 2022.

BIOSIMILARS

Currently, 14 biosimilars have been approved in the United States compared with 45 biosimilars approved by the European Union. Of these 14 biosimilars, only 4 have launched. “Support for biosimilars remains high, but uptake is met with challenges,” Long said in the presentation. Barriers to biosimilar uptake are multifaceted and include rebate practices and lifecycle management strategies by brand sponsors, confusing policy language, and stakeholder education and awareness. Long said that legislative action may be needed to overcome patent disputes that can delay product entry. Still, biosimilar use remains a potential strategy to lower drug costs, with the Trump administration in favor of legislation aimed at fostering more competition in the space.

Articles in this issue

CMS Update: Policy Initiatives Tackle Drug Pricing, Coverage Reform
CMS Update: Policy Initiatives Tackle Drug Pricing, Coverage Reform
The Era of Specialty: An Update on Current Industry Trends
The Era of Specialty: An Update on Current Industry Trends
Benralizumab for Severe Eosinophilic Asthma
Benralizumab for Severe Eosinophilic Asthma
Annual NASP Meeting Kicks Off With a Renewed Call for Advocacy
Annual NASP Meeting Kicks Off With a Renewed Call for Advocacy
Oncology Pipeline Highlights: A Look at Current and Future Developments
Oncology Pipeline Highlights: A Look at Current and Future Developments
Former House Speaker Calls for Overhaul of Health Care System During NASP Keynote Speech
Former House Speaker Calls for Overhaul of Health Care System During NASP Keynote Speech
Takhzyro for Hereditary Angioedema
Takhzyro for Hereditary Angioedema
Health-System Specialty Pharmacies Becoming an Industry Cornerstone
Health-System Specialty Pharmacies Becoming an Industry Cornerstone
Health Care Economic Information and Its Impact on Value-Based Contracts
Health Care Economic Information and Its Impact on Value-Based Contracts
Responding Proactively to Antikickback Guidelines
Responding Proactively to Antikickback Guidelines
No Simple Answers for Lowering Drug Costs
No Simple Answers for Lowering Drug Costs
The Brave New World of 340B: Where Do We Go From Here?
The Brave New World of 340B: Where Do We Go From Here?
Hemophilia Advancements and the Evolution of Patient Management
Hemophilia Advancements and the Evolution of Patient Management
Just 2 CSTD Products Pass NIOSH’s 2015 Vapor Containment Performance Protocol
Just 2 CSTD Products Pass NIOSH’s 2015 Vapor Containment Performance Protocol
The Drug Pricing Debate Is Finally Shining a Light on Pharmacy Benefit Managers
The Drug Pricing Debate Is Finally Shining a Light on Pharmacy Benefit Managers
Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs
Related Content
Advertisement
Focuses on medical shield icon with healthcare symbols like hospital, Health Insurance and Medical Care Concept. doctor, medicine, and emergency care - Image credit: Jim | stock.adobe.com
May 13th 2025

May 2025 Pharmacy Policy

Aislinn Antrim, Managing Editor
Pharmacist Spotlight: Juliana Chan, PharmD, FCCP, BCACP
May 13th 2025

Pharmacist Spotlight: Juliana Chan, PharmD, FCCP, BCACP

Juliana Chan, PharmD, FCCP, BCACP PT Staff
Vaccine - Image credit: anidimi | stock.adobe.com
May 12th 2025

Vaccines Are Entering a Period of Simultaneous Expansion and Contraction

Troy Trygstad, PharmD, PhD, MBA, Pharmacy Times Editor in Chief
Man receiving a vaccine -- Image credit: Prostock-studio | stock.adobe.com
May 12th 2025

Advancing Patient Safety: Pharmacist-Led Strategies in Vaccination, Antimicrobial Stewardship, and Nutrient Management

Mike Hennessy Jr, President and CEO
Person filling out application form -- Image credit: emiliezhang | stock.adobe.com
May 12th 2025

The Evolving Fellowship Application Process

Elena Tormo, PharmD, RPh Gerardo Gutierrez, PharmD Stephanie Conway-Allen, PharmD, RPh
Pharmacy students -- Image credit: luckybusiness | stock.adobe.com
May 9th 2025

Student Advocacy in Pharmacy

Nikol Muslimovic, PharmD Candidate Abby Renae Allenbaugh, PharmD Candidate Sophia Herbert, PharmD
Related Content
Advertisement
Focuses on medical shield icon with healthcare symbols like hospital, Health Insurance and Medical Care Concept. doctor, medicine, and emergency care - Image credit: Jim | stock.adobe.com
May 13th 2025

May 2025 Pharmacy Policy

Aislinn Antrim, Managing Editor
Pharmacist Spotlight: Juliana Chan, PharmD, FCCP, BCACP
May 13th 2025

Pharmacist Spotlight: Juliana Chan, PharmD, FCCP, BCACP

Juliana Chan, PharmD, FCCP, BCACP PT Staff
Vaccine - Image credit: anidimi | stock.adobe.com
May 12th 2025

Vaccines Are Entering a Period of Simultaneous Expansion and Contraction

Troy Trygstad, PharmD, PhD, MBA, Pharmacy Times Editor in Chief
Man receiving a vaccine -- Image credit: Prostock-studio | stock.adobe.com
May 12th 2025

Advancing Patient Safety: Pharmacist-Led Strategies in Vaccination, Antimicrobial Stewardship, and Nutrient Management

Mike Hennessy Jr, President and CEO
Person filling out application form -- Image credit: emiliezhang | stock.adobe.com
May 12th 2025

The Evolving Fellowship Application Process

Elena Tormo, PharmD, RPh Gerardo Gutierrez, PharmD Stephanie Conway-Allen, PharmD, RPh
Pharmacy students -- Image credit: luckybusiness | stock.adobe.com
May 9th 2025

Student Advocacy in Pharmacy

Nikol Muslimovic, PharmD Candidate Abby Renae Allenbaugh, PharmD Candidate Sophia Herbert, PharmD
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.